After Hours
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility.
Stocks Info
ARTV belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Artiva Biotherapeutics Inc is $249.21M. A total of 62378.0 shares were traded on the day, compared to an average of 62.08K shares.
In the most recent transaction, RA CAPITAL MANAGEMENT, L.P. bought 8,333,333 shares of ARTV for 12.00 per share on Jul 22 ’24. After the transaction, the Director now owns 8,693,579 company shares. In a previous transaction on Jul 22 ’24, 5AM Partners VI, LLC bought 833,333 shares at 12.00 per share. ARTV shares that 10% Owner owns now total 1,182,054.
Among the insiders who bought shares, venBio Global Strategic Fund I acquired of 416,666 shares on Jul 22 ’24 at a per-share price of $12.00. This resulted in the 10% Owner holding 1,936,637 shares of ARTV after the transaction. In another insider transaction, GC Corp. bought 1,666,666 shares at $12.00 per share on Jul 22 ’24. Company shares held by the 10% Owner now total 3,306,900.
While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, ARTV has a high of $17.31 and a low of $9.68.
Balance Sheet Annually/Quarterly
An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. ARTV’s latest balance sheet shows that the firm has $160.92M in Cash & Short Term Investments as of fiscal 2021. There were $1.74M in debt and $19.30M in liabilities at the time. Its Book Value Per Share was $8.28, while its Total Shareholder’s Equity was -$88.86M.
Analysts Opinion
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARTV is Buy with a score of 4.83.